NCT05209568View on ClinicalTrials.gov

Immune Responses to Gluten

NARecruitingINTERVENTIONAL
Enrollment

400

Participants

Timeline

Start Date

January 15, 2023

Primary Completion Date

September 30, 2028

Study Completion Date

September 30, 2029

Conditions
Celiac DiseaseMalabsorption SyndromesDigestive System DiseaseIntestinal DiseaseGastrointestinal DiseasesGluten SensitivityCeliac Disease in Children
Interventions
DIETARY_SUPPLEMENT

Gluten Powder

Single oral dose of gluten powder

Trial Locations (2)

80045

RECRUITING

Children's Hospital Colorado, Aurora

02115

RECRUITING

Boston Children's Hospital, Boston

All Listed Sponsors
collaborator

Children's Hospital Colorado

OTHER

collaborator

Celiac Disease Foundation

UNKNOWN

lead

Boston Children's Hospital

OTHER